Valuation check: MTD's profit margin is 21.91%, above the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Mettler-Toledo International (MTD) currently reports a profit margin of 21.91% as of June 2026. That compares with 21.46% in the prior-year period — up 2.1% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Mettler-Toledo International's profit margin history and peer comparisons.
Mettler-Toledo International's profit margin increased from 21.46% to 21.91% — a 2.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Mettler-Toledo International's profit margin of 21.91% is higher than the Healthcare sector average of 13.89%. That is roughly 57.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Mettler-Toledo International's current 21.91% should be judged against Healthcare norms (sector average: 13.89%) and against MTD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 21.91%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Mettler-Toledo International, and consider following MTD for alerts when major investors trade the stock.